Skip to main content
Terug
Watch Compare

Cosmos Health Inc.

Datakwaliteit: 100%
COSM
NASDAQ Wholesale Trade Nondurable Goods Wholesale
€ 0,39
▲ € 0,06 (17,07%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-0,45%

Groei

Revenue Growth (5Y)
-0,45%
Onder sectorgemiddelde (2,60%)
Revenue (1Y)1,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-75,12%
Onder sectorgemiddelde (-4,23%)
ROIC-36,57%
Net Margin-31,01%
Op. Margin-23,86%

Veiligheid

Debt / Equity
0,23
Onder sectorgemiddelde (0,32)
Current Ratio0,99
Interest Coverage-9,12

Waardering

PE (TTM|NTM|2027)
-0,58 | 5,59 | 4,14
Onder sectorgemiddelde (-0,16)
P/B Ratio0,47
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -0,45% annually over 5 years
Debt/Equity of 0,23 — conservative balance sheet
Negative free cash flow of -7,81 M
Capital efficient — spends only 0,20% of revenue on capex

Price History

Financiële Trends

Koersdoel Analisten

1 analist
Hold
+1050.9%
upside to target
Huidig
€ 0,39
Consensus Target
€ 4,50
€ 4,50
Laag
€ 4,50
Hoog
Vooruitzicht
Forward K/W
5,59
Forward WPA
€ 0,07
Omzet Sch.
130,80 M

Winstverassingen

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -€ 0,07 · Rev Est: 20,70 M
Q32025 Q42025 Q1 '26 Q2 '26
Reported -€ 0,17 -€ 0,36 — —
Estimate — -€ 0,04 -€ 0,07 -€ 0,03
Verrassing — -809,75% — —

Growth

Rev 5Y: -0,45% · Earnings 1Y: N/A
Revenue Growth (1Y) 1,97% Revenue Growth (3Y) 3,97%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -0,45% Earnings Growth (5Y) N/A

Profitability

ROE: -75,12% · Net Margin: -31,01%
Revenue (TTM) 59,79 M Net Income (TTM) -18,54 M
ROE -75,12% ROA -28,24%
Gross Margin 11,41% Operating Margin -23,86%
Net Margin -31,01% Free Cash Flow (TTM) -7,81 M
ROIC -36,57% FCF Growth (3Y) N/A

Safety

D/E: 0,23 · Current: 0,99
Debt / Equity 0,23 Current Ratio 0,99
Interest Coverage -9,12 Asset Turnover 0,91
Working Capital -430.028 Tangible Book Value 15,17 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0,58 · EV/EBITDA: N/A
P/E Ratio -0,58 Forward P/E 5,59
P/B Ratio 0,47 P/S Ratio 0,18
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,08 Fwd Earnings Yield 17,89%
FCF Yield -72,24%
Market Cap 10,80 M Enterprise Value 15,28 M

Per Share

EPS: -0,77 · FCF/Share: -0,21
EPS (Diluted TTM) -0,77 Revenue / Share 1,60
FCF / Share -0,21 OCF / Share -0,21
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 42,10% · CapEx/Rev: 0,20%
CapEx / Revenue 0,20% FCF Conversion 42,10%
SBC-Adj. FCF -9,96 M Growth Momentum 2,42

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 54,43 M 53,38 M 50,35 M 56,24 M 55,41 M
Net Income -16,18 M -18,54 M -13,83 M -7,96 M 820.786,0
EPS (Diluted) -1,17 -2,15 -33,16 -0,95 0,06
Gross Profit 4,31 M 4,35 M 5,96 M 8,33 M 8,06 M
Operating Income -15,54 M -21,83 M -7,47 M -4,53 M 2,71 M
EBITDA — — — — —
R&D Expenses 533.293,0 — — — —
SG&A Expenses — — — — —
D&A 1,25 M 614.377,0 103.194,0 449.692,0 397.595,0
Interest Expense 1,01 M 866.476,0 2,35 M 2,82 M 3.910,0
Income Tax 0,0 -775.051,0 775.051,0 -114.010,0 377.535,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 54,31 M 66,01 M 68,04 M 49,43 M 43,84 M
Total Liabilities 29,78 M 29,97 M 28,38 M 45,05 M 48,01 M
Shareholders' Equity 24,53 M 36,04 M 39,28 M 4,38 M -4,16 M
Total Debt 4,11 M 4,61 M 5,02 M 17,91 M 10,77 M
Cash & Equivalents — — 20,75 M 286.487,0 628.395,0
Current Assets 25,46 M 36,61 M 56,04 M 40,88 M 40,77 M
Current Liabilities 25,76 M 24,32 M 21,75 M 29,93 M 34,79 M

Sectorvergelijking

vs Wholesale Trade sector mediaan (100 peers)
Metriek Aandeel Sector Mediaan
P/E -0,6 -0,2
P/B 0,5 1,0
ROE % -75,1 -4,2
Net Margin % -31,0 -2,4
Rev Growth 5Y % -0,5 2,6
D/E 0,2 0,3